isomethyleugenol has been researched along with Neuroectodermal Tumors, Primitive, Peripheral in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, L; Chen, T; Fan, Q; Huang, S; Jiang, J; Li, H; Liang, T; Liu, C; Qu, H; Sun, X; Yao, Y; Zhan, X | 1 |
1 other study(ies) available for isomethyleugenol and Neuroectodermal Tumors, Primitive, Peripheral
| Article | Year |
|---|---|
Novel prognostic biomarkers, METTL14 and YTHDF2, associated with RNA methylation in Ewing's sarcoma.
Topics: Biomarkers; Humans; Methylation; Methyltransferases; Neuroectodermal Tumors, Primitive, Peripheral; Prognosis; RNA; RNA-Binding Proteins; Sarcoma, Ewing; Transcription Factors | 2022 |